Evidence map›Paper›PMID 32059447›Full record

ReviewCancers2020

Bench to Bedside: Animal Models of Radiation Induced Musculoskeletal Toxicity.

Michael K Farris, Corbin A Helis, Ryan T Hughes, Michael C LeCompte, Alexander M Borg, Karina Nieto, Michael T Munley, Jeffrey S Willey

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. FeBioengineering (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Relative Effects of Radiation-Induced Changes in Bone Mass, Structure, and Tissue Material on Vertebral Strength in a Rat Model.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2023
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Michael K FarrisDepartment of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Corbin A HelisDepartment of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Ryan T HughesDepartment of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Michael C LeCompteDepartment of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Alexander M BorgDepartment of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Karina NietoDepartment of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Michael T MunleyDepartment of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Jeffrey S WilleyDepartment of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Wake Forest University · US

Funding

Targeting IRE-1α to protect against radiation therapy-induced bone lossR21AR072806 · NIAMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI WILLEY, JEFFREY S · 2018 to 2019
$381k
NIAMS NIH HHS R21 AR072806NIH HHS R21AR072806
6 · The paper itself

Abstract

Ionizing radiation is a critical aspect of current cancer therapy. While classically mature bone was thought to be relatively radio-resistant, more recent data have shown this to not be the case. Radiation therapy (RT)-induced bone loss leading to fracture is a source of substantial morbidity. The mechanisms of RT likely involve multiple pathways, including changes in angiogenesis and bone vasculature, osteoblast damage/suppression, and increased osteoclast activity. The majority of bone loss appears to occur rapidly after exposure to ionizing RT, with significant changes in cortical thickness being detectable on computed tomography (CT) within three to four months. Additionally, there is a dose-response relationship. Cortical thinning is especially notable in areas of bone that receive >40 gray (Gy). Methods to mitigate toxicity due to RT-induced bone loss is an area of active investigation. There is an accruing clinical trial investigating the use of risderonate, a bisphosphonate, to prevent rib bone loss in patients undergoing lung stereotactic body radiation therapy (SBRT). Additionally, several other promising therapeutic/preventative approaches are being explored in preclinical studies, including parathyroid hormone (PTH), amifostine, and mechanical loading of irradiated bones.

Indexed as

cortical thickness mappingfracturenormal bone toxicityosteoblastosteoclastradiation therapySBRT

Identifiers

PMID32059447
PMCPMC7073177
OpenAlexW3006064960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.